- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +14 more
- Locations
-
- Institut Jules Bordet Anderlecht, Belgium
- CHC MontLegia Liège, Belgium
- St. Elisabeth-Krankenhaus GmbH, Brustzentrum - Senologie Cologne, North Rhine-Westphalia, Germany
- Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
Clinical trial condition
HR-Positive Breast Cancer
Explore clinical trials studying HR-Positive Breast Cancer. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
HR-Positive Breast Cancer trial results
- Conditions
- Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
- Locations
-
- Centro di Riferimento Oncologico IRCCS Aviano, Italy
- Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
- Humanitas Istituto Clinico Catanese Catania, Italy
- ASST Lariana - Ospedale Sant'Anna Como, Italy
Active, Not Recruiting
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
NCT04448886
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +7 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- DFCI @ Foxborough Foxborough, Massachusetts, United States